Sunshine Biopharma (SBFM) Balance Sheet: Assets & Liabilities

Sunshine Biopharma (SBFM) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Sunshine Biopharma reported total assets of $30.08M and total liabilities of $7.04M. Shareholders' equity was $23.04M, down 2.0% from $23.50M a year earlier. Total debt stood at $812.42K against $9.12M in cash and short-term investments, a net cash position of $8.31M. That puts debt-to-equity at 0.04, compared with 0.04 a year earlier.

Sunshine Biopharma Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Sunshine Biopharma, Inc. (SBFM) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Mar 2024	Dec 2023	Mar 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	9.12	9.69	16.29	16.29	21.83	21.83	2.05	0.99	0.04	0.12	0.11
Short-Term Investments	0.00	0.00	0.00	-	0.00	-	0.00	0.01	0.01	0.00	0.00
Cash & Short-Term Investments	9.12	9.69	16.29	16.29	21.83	21.83	2.05	1.00	0.05	0.12	0.11
Accounts Receivable	3.46	3.87	2.55	2.55	1.91	1.91	0.01	0.00	0.00	0.00	0.00
Inventory	13.47	11.28	5.73	5.73	3.29	3.29	0.11	0.02	0.02	0.00	-0.01
Other Current Assets	0.80	1.13	0.31	0.31	0.28	0.28	0.04	0.00	0.00	0.99	0.01
Total Current Assets	26.85	25.97	24.89	24.89	27.31	27.31	2.20	1.03	0.07	0.21	0.12
Non-Current Assets
Property, Plant & Equipment (Net)	1.34	1.48	1.01	1.01	1.15	1.15	0.01	0.02	0.03	0.27	0.06
Goodwill	0.00	0.00	0.00	-	0.00	-	0.00	0.00	0.00	0.67	0.00
Intangible Assets	1.89	3.02	1.44	1.44	0.78	0.78	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	-	0.00	-	0.00	0.00	0.00	0.00	0.08
Total Non-Current Assets	3.23	4.59	2.46	2.46	2.23	1.93	0.01	0.02	0.03	0.94	0.14
Total Assets	30.08	30.56	27.35	27.35	29.55	29.24	2.20	1.05	0.10	1.15	0.26
Current Liabilities
Accounts Payable	5.66	5.54	2.59	2.59	2.80	2.80	0.04	0.06	0.10	0.12	0.02
Short-Term Debt	0.22	0.21	0.12	-	0.12	3.63	0.00	0.96	0.72	0.66	0.72
Current Portion of Long-Term Debt	-	-	-	-	-	-	-	0.82	-	-	-
Accrued Liabilities	-	-	-	-	-	-	0.05	0.02	-	-	-
Deferred Revenue	0.00	0.00	0.00	-	0.00	-	0.00	0.00	0.00	0.05	0.00
Other Current Liabilities	0.30	0.30	2.55	2.85	3.63	0.12	0.05	0.02	0.02	0.13	0.01
Total Current Liabilities	6.44	6.31	5.55	5.55	6.93	6.93	0.09	1.05	0.83	0.91	0.75
Non-Current Liabilities
Long-Term Debt	0.60	0.74	0.54	0.54	0.64	0.64	1.90	0.95	0.00	0.29	0.08
Deferred Tax Liabilities	0.00	0.00	0.05	0.05	0.34	0.04	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.05	0.00	0.04	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.60	0.74	0.59	0.59	0.99	0.69	1.90	0.95	0.00	0.29	0.08
Total Liabilities	7.04	7.06	6.14	6.14	7.92	7.62	1.99	2.00	0.83	1.20	0.83
Stockholders' Equity
Common Stock	0.00	0.00	0.03	0.00	0.02	0.02	0.00	0.00	0.04	0.09	0.92
Retained Earnings	-75.02	-69.04	-63.91	-63.91	-59.40	-59.40	-32.66	-20.22	-17.43	-15.77	-13.62
Accumulated Other Comprehensive Income	-0.07	-0.83	0.70	0.70	0.16	0.16	-0.02	0.00	0.00	0.00	0.00
Additional Paid-in Capital	98.10	93.35	84.39	84.42	80.84	80.84	32.79	19.17	16.62	15.67	12.08
Shares Outstanding	0.49	0.26	-	0.00	-	0.00	0.00	-	-	-	-
Total Stockholders' Equity	23.04	23.50	21.21	21.21	21.63	21.63	0.21	-0.95	-0.74	-0.06	-0.57
Total Liabilities & Equity	30.08	30.56	27.35	27.35	29.55	29.24	2.20	1.05	0.10	1.15	0.26

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Sunshine Biopharma Balance Sheet

How much debt does Sunshine Biopharma have?

Sunshine Biopharma had total debt of $812.42K as of Dec 31, 2025, against $9.12M in cash and short-term investments. Its debt-to-equity ratio was 0.04. Total debt was $952.48K a year earlier.

What are Sunshine Biopharma's total assets?

Sunshine Biopharma reported total assets of $30.08M as of Dec 31, 2025, down 1.6% from $30.56M a year earlier. Total liabilities were $7.04M.

What is Sunshine Biopharma's shareholders' equity?

Sunshine Biopharma's shareholders' equity was $23.04M as of Dec 31, 2025, or about $46.96 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition